8/29/2023
Join us for a four-part online seminar series to learn how advanced biotherapeutic characterization technologies from Waters can help laboratories achieve the standards of regulatory bodies around the world to produce sufficient analytical and biological evidence of similarity between innovator and biosimilar candidates that will reduce the clinical trial burden for approval.
§ How Waters consumables enable high quality peptide mapping, glycan and charge variant data.
§ A case study of biosimilar mAb characterization at intact, subunit, and peptide level.
§ How to improve assay robustness and reduce the burden associated with migrating methods downstream in the analysis and monitoring of PQAs of biopharmaceuticals.
Episode 1: Thursday, September 21stChromatographic Techniques for the Characterization of CQAs in Biosimilars
Episode 2: Thursday, September 28thRobust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment
Episode 3: Thursday, October 5thAdvancing Technology for Better Medicine
Episode 4: Thursday, October 12thHear a customer perspective on deploying Waters solutions to enhance biosimilar development
Click below to view the full agenda and register. You have the option to select individual or all presentations.
Register Today
Sign up to Hellamco's Mailing List and check out our latest news. HELLAMCO S.A. will process your personal data only for communication and updating purposes, will not distribute them on to third parties and will keep them in the database for 30 days. For more information regarding the processing of personal data and rights, please visit our relative privacy policy.
Invalid Email
Subscription successfull